Pertti J. Pentikäinen

1.2k total citations
32 papers, 937 citations indexed

About

Pertti J. Pentikäinen is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Pertti J. Pentikäinen has authored 32 papers receiving a total of 937 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 8 papers in Surgery and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Pertti J. Pentikäinen's work include Heart Failure Treatment and Management (8 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Pertti J. Pentikäinen is often cited by papers focused on Heart Failure Treatment and Management (8 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Pertti J. Pentikäinen collaborates with scholars based in Finland, United States and Estonia. Pertti J. Pentikäinen's co-authors include Lasse Lehtonen, Saila Antila, Daniel L. Azarnoff, Matti Kivikko, Jaan Eha, David H. Huffman, Pekka Ottoila, Don W. Shoeman, Carlos A. Dujovne and Suk Han Wan and has published in prestigious journals such as The Lancet, Gastroenterology and The American Journal of Cardiology.

In The Last Decade

Pertti J. Pentikäinen

32 papers receiving 854 citations

Peers

Countries citing papers authored by Pertti J. Pentikäinen

Since Specialization

Citations

This map shows the geographic impact of Pertti J. Pentikäinen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pertti J. Pentikäinen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pertti J. Pentikäinen more than expected).

Fields of papers citing papers by Pertti J. Pentikäinen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pertti J. Pentikäinen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pertti J. Pentikäinen. The network helps show where Pertti J. Pentikäinen may publish in the future.

Co-authorship network of co-authors of Pertti J. Pentikäinen

This figure shows the co-authorship network connecting the top 25 collaborators of Pertti J. Pentikäinen. A scholar is included among the top collaborators of Pertti J. Pentikäinen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pertti J. Pentikäinen. Pertti J. Pentikäinen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Laboratory tests as predictors of the antihypertensive effects of amlodipine, bisoprolol, hydrochlorothiazide and losartan in men: results from the randomized, double-blind, crossover GENRES Study 2008 ·Journal of Hypertension ·(unknown), Tuula Hannila‐Handelberg, Kristian Paavonen, Helena E. Miettinen, Kati Donner, Timo Strandberg, Ilkka Tikkanen, Reijo S. Tilvis, Pertti J. Pentikäinen, Kimmo Kontula, Timo P. Hiltunen	24
2	Pharmacokinetics of Intravenous Levosimendan and Its Metabolites in Subjects With Hepatic Impairment 2008 ·The Journal of Clinical Pharmacology ·(unknown), (unknown), (unknown), (unknown), Sari Häkkinen, Matti Kivikko, Pertti J. Pentikäinen	25
3	Pharmacokinetics and excretion balance of OR-1896, a pharmacologically active metabolite of levosimendan, in healthy men 2007 ·European Journal of Pharmaceutical Sciences ·(unknown), (unknown), (unknown), Sari Häkkinen, Wenhui Zhang, Rajendra Pradhan, Pertti J. Pentikäinen, Mikko Koskinen	17
4	Pharmacokinetics of levosimendan and its circulating metabolites in patients with heart failure after an extended continuous infusion of levosimendan 2004 ·British Journal of Clinical Pharmacology ·Saila Antila, Matti Kivikko, Lasse Lehtonen, Jaan Eha, (unknown), Pasi Pohjanjousi, Pertti J. Pentikäinen	55
5	Pharmacodynamics and Safety of a New Calcium Sensitizer, Levosimendan, and Its Metabolites during an Extended Infusion in Patients with Severe Heart Failure 2002 ·The Journal of Clinical Pharmacology ·Matti Kivikko, Saila Antila, Jaan Eha, Lasse Lehtonen, Pertti J. Pentikäinen	102
6	Main results of the losartan versus amlodipine (LOA) study on drug tolerability and psychological general well-being 1997 ·Journal of Hypertension ·Björn Dahlöf, Lars Lindholm, Shane Carney, Pertti J. Pentikäinen, Jan Östergren	43
7	Pharmacokinetics of Levosimendan in Healthy Volunteers and Patients with Congestive Heart Failure 1995 ·Journal of Cardiovascular Pharmacology ·(unknown), (unknown), Saila Antila, (unknown), Pekka Ottoila, Lasse Lehtonen, Pertti J. Pentikäinen	82
8	Pharmacokinetics of Levosimendan in Healthy Volunteers and Patients with Congestive Heart Failure 1995 ·Journal of Cardiovascular Pharmacology ·(unknown), (unknown), Saila Antila, (unknown), Pekka Ottoila, Lasse Lehtonen, Pertti J. Pentikäinen	80
9	Comparative Pharmacokinetics of Lovastatin, Simvastatin and Pravastatin in Humans 1992 ·The Journal of Clinical Pharmacology ·Pertti J. Pentikäinen, Markku Saraheimo, Jules I. Schwartz, Raju D. Amin, Michael S. Schwartz, Françoise Brunner‐Ferber, John Rogers	86
10	Cholesterol Lowering Effect of Metformin in Combined Hyperlipidemia: Placebo Controlled Double Blind Trial 1990 ·Annals of Medicine ·Pertti J. Pentikäinen, Erkki Voutilainen, Antti Aro, Matti Uusitupa, Ilkka Penttilä, Heikki Vapaatalo	45
11	Diseases and drugs causing prolongation of the QT interval 1987 ·The American Journal of Cardiology ·Markku Laakso, (unknown), (unknown), Pertti J. Pentikäinen, Kalevi Pyörälà	48
12	Human metabolism of tolfenamic acid. II. Structure of metabolites and C-13 NMR assignments of fenamates 1982 ·European Journal of Drug Metabolism and Pharmacokinetics ·Raja G. Khalifah, Charles E. Hignite, Pertti J. Pentikäinen, (unknown), Pertti J. Neuvonen	12
13	Pharmacokinetics of intravenously administered bumetanide in man 1980 ·Journal of Pharmacokinetics and Biopharmaceutics ·Pertti J. Pentikäinen, Pertti J. Neuvonen, M. Kekki, (unknown)	28
14	Pharmacokinetics of digoxin in patients with acute myocardial infarction 1979 ·The American Journal of Cardiology ·Ulla R. Korhonen, A. J. Jounela, A. Pakarinen, Pertti J. Pentikäinen, Juha T. Takkunen	10
15	Pamatolol: Phase I evaluation of the pharmacodynamics of a cardioselective beta adrenoceptor blocking drug 1978 ·Clinical Pharmacology & Therapeutics ·S. George Carruthers, (unknown), Pertti J. Pentikäinen, Daniel L. Azarnoff	7
16	A two-year crossover therapeutic trial with halofenate and clofibrate 1976 ·The American Journal of the Medical Sciences ·Carlos A. Dujovne, Daniel L. Azarnoff, Pertti J. Pentikäinen, Carl V. Manion, Aryeh Hurwitz, Khatab M. Hassanein	10
17	Bioavailability of Aminosalicylic Acid and Its Various Salts in Humans III: Absorption from Tablets 1974 ·Journal of Pharmaceutical Sciences ·Suk Han Wan, Pertti J. Pentikäinen, Daniel L. Azarnoff	21
18	Bioavailability studies on para-aminosalicylic acid and its various salts in man. I. Absorption from solution and suspension 1974 ·Journal of Pharmacokinetics and Biopharmaceutics ·Suk Han Wan, Pertti J. Pentikäinen, Daniel L. Azarnoff	13
19	Bioavailability of Aminosalicylic Acid and its Various Salts in Humans IV: Comparison of Four Brands of the Sodium Salt 1974 ·Journal of Pharmaceutical Sciences ·Pertti J. Pentikäinen, Daniel L. Azarnoff, Suk Han Wan	6
20	The Effect of Spironolactone on Antipyrine Metabolism in Man 1973 ·Pharmacology ·David H. Huffman, Don W. Shoeman, Pertti J. Pentikäinen, Daniel L. Azarnoff	62

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact